PML and PML nuclear bodies: implications in antiviral defence
- PMID: 17343971
- DOI: 10.1016/j.biochi.2007.01.004
PML and PML nuclear bodies: implications in antiviral defence
Abstract
The establishment of an intracellular antiviral state is the defining activity of interferons (IFNs) as well as the property that permitted their discovery. Several pathways have been implicated in resistance to viral infection in IFN-treated cells, one of which implicates the ProMyelocytic Leukaemia (PML) protein and PML nuclear bodies (NBs, also known as ND10). PML NBs are dynamic intranuclear structures that require PML for their formation and which harbour numerous other transiently or permanently localised proteins. PML is expressed as a family of isoforms (PML I-VII) as a result of alternative splicing, most of which are found in the nucleus. IFN treatment directly induces transcription of the genes encoding both PML and Sp100, (another major component of PML NBs), resulting in higher levels of expression of these proteins and increases in both the size and number of PML NBs. These and other observations have encouraged the hypothesis that PML, PML NBs and a number of other constituents of these structures are involved in host antiviral defences. For example, exogenous expression of PML III or PML VI can impede infection by a number of RNA and DNA viruses, and certain viral proteins accumulate in PML NBs then cause their disruption by a variety of mechanisms. Although there are many other functions of PML NBs in a wide range of cellular pathways, there is accumulating evidence that they represent preferential targets for viral infections and that PML plays a role in the mechanism of the antiviral action of IFN. This article reviews the potential antiviral activities of PML NB constituent proteins, how RNA and DNA viruses overcome these defences, and the connections between these events and IFN pathways.
Similar articles
-
Role and fate of PML nuclear bodies in response to interferon and viral infections.Oncogene. 2001 Oct 29;20(49):7274-86. doi: 10.1038/sj.onc.1204854. Oncogene. 2001. PMID: 11704856 Review.
-
PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery.PLoS Pathog. 2019 Feb 25;15(2):e1007590. doi: 10.1371/journal.ppat.1007590. eCollection 2019 Feb. PLoS Pathog. 2019. PMID: 30802273 Free PMC article.
-
Role of promyelocytic leukemia protein in host antiviral defense.J Interferon Cytokine Res. 2011 Jan;31(1):145-58. doi: 10.1089/jir.2010.0111. Epub 2011 Jan 3. J Interferon Cytokine Res. 2011. PMID: 21198351 Review.
-
Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.Virulence. 2011 Jan-Feb;2(1):58-62. doi: 10.4161/viru.2.1.14610. Epub 2011 Jan 1. Virulence. 2011. PMID: 21217204
-
Dynamics of component exchange at PML nuclear bodies.J Cell Sci. 2008 Aug 15;121(Pt 16):2731-43. doi: 10.1242/jcs.031922. Epub 2008 Jul 29. J Cell Sci. 2008. PMID: 18664490
Cited by
-
Murine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradation.Virology. 2013 Jun 5;440(2):140-9. doi: 10.1016/j.virol.2013.02.014. Epub 2013 Mar 27. Virology. 2013. PMID: 23541081 Free PMC article.
-
Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape.World J Virol. 2016 Aug 12;5(3):87-96. doi: 10.5501/wjv.v5.i3.87. World J Virol. 2016. PMID: 27563536 Free PMC article. Review.
-
Transcriptional activation of the adenoviral genome is mediated by capsid protein VI.PLoS Pathog. 2012 Feb;8(2):e1002549. doi: 10.1371/journal.ppat.1002549. Epub 2012 Feb 23. PLoS Pathog. 2012. PMID: 22427750 Free PMC article.
-
HSV-1 ICP0 dimer domain adopts a novel β-barrel fold.Proteins. 2024 Jul;92(7):830-841. doi: 10.1002/prot.26673. Epub 2024 Feb 19. Proteins. 2024. PMID: 38372168
-
Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.J Virol. 2010 May;84(9):4383-94. doi: 10.1128/JVI.02369-09. Epub 2010 Feb 24. J Virol. 2010. PMID: 20181712 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous